About the Journal
Key Features Editorial Board Editorial Contacts American Association of Certified Allergists RSLAAIS History RSLAAIS Participating Societies History
Read Content
Subscribe
Individual Subscription Order/Renewal Agent Order/Renewal Institution Order/Renewal Commercial Order/Renewal Activate Subscription Online Journal Content Alerts eTOC
For Authors
Instructions to Authors Publishing Forms Submit a Manuscript FastTrack Service Expedited Manuscript Service Open Access Option Why Publish in AAP?
Primers
NWS for Allergy-Immunology Allergen Immunotherapy (AIT) Primer Hereditary Angloedema Primer POPs in the Past Drug Allergy and Protocols for Management of Drug Allergies Immunodeficiency Primer
Permission to Use Content
Reprints
Subscribe to AAP

Allergy & Asthma Proceedings

Why Publish in AAP?

  • Internationally known Editor-in-Chief: Joseph A. Bellanti, MD
  • Indexed: MEDLINE®, PubMed®
  • Impact factor: 2.6
  • Targeted to and peer reviewed by allergy/immunology specialists
  • Responsive editorial team
  • Rapid Publication: No backlog
  • Expedited manuscript services available
  • Print circulation: 5,000 Allergy/Immunology clinicians
  • Wide e-distribution: >41,000 eTOC recipients
  • Content online at Ingenta Connect

Advertise in this journal

Advertise Now